All Stories

  1. Activation of sterol regulatory element-binding protein 1 (SREBP1)-mediated lipogenesis by the Epstein-Barr virus-encoded latent membrane protein 1 (LMP1) promotes cell proliferation and progression of nasopharyngeal carcinoma
  2. The Dynamic Roles of TGF-β Signalling in EBV-Associated Cancers
  3. The EBV-Encoded Oncoprotein, LMP1, Induces an Epithelial-to-Mesenchymal Transition (EMT) via Its CTAR1 Domain through Integrin-Mediated ERK-MAPK Signalling
  4. Epstein–Barr virus: more than 50 years old and still providing surprises
  5. Erratum: Epstein-Barr virus and carcinomas: rare association of the virus with gastric adenocarcinomas
  6. The Epstein-Barr virus encoded LMP1 oncoprotein modulates cell adhesion via regulation of activin A/TGFβ and β1 integrin signalling
  7. Activation of the FGFR1 signalling pathway by the Epstein-Barr virus-encoded LMP1 promotes aerobic glycolysis and transformation of human nasopharyngeal epithelial cells
  8. Genome Diversity of Epstein-Barr Virus from Multiple Tumor Types and Normal Infection
  9. Epstein-Barr virus and nasopharyngeal carcinoma
  10. Epstein-Barr virus at 50-future perspectives
  11. Fas-associated factor (Faf1) is a novel CD40 interactor that regulates CD40-induced NF-κB activation via a negative feedback loop
  12. Epstein-Barr virus induction of the Hedgehog signalling pathway imposes a stem cell phenotype on human epithelial cells
  13. Inhibition of the LKB1-AMPK pathway by the Epstein-Barr virus-encoded LMP1 promotes proliferation and transformation of human nasopharyngeal epithelial cells
  14. A Global View of the Oncogenic Landscape in Nasopharyngeal Carcinoma: An Integrated Analysis at the Genetic and Expression Levels
  15. Smoking initiation is followed by the early acquisition of epigenetic change in cervical epithelium: a longitudinal study
  16. Phase I/II trial of a dendritic cell vaccine transfected with DNA encoding melan A and gp100 for patients with metastatic melanoma
  17. Epstein–Barr virus and carcinogenesis: beyond Burkitt's lymphoma
  18. The EBV-encoded latent membrane proteins, LMP2A and LMP2B, limit the actions of interferon by targeting interferon receptors for degradation
  19. The Epstein-Barr virus oncoprotein, latent membrane protein-1, reprograms germinal centre B cells towards a Hodgkin's Reed-Sternberg-like phenotype
  20. Combining gene and immunotherapy for prostate cancer
  21. Epstein–Barr virus-encoded EBNA1 regulates cellular gene transcription and modulates the STAT1 and TGFβ signaling pathways
  22. The natural history of cervical HPV infection: unresolved issues
  23. The polycomb group proteins, BMI-1 and EZH2, are tumour-associated antigens
  24. Inhibition of NF-κB enhances the cytotoxicity of virus-directed enzyme prodrug therapy and oncolytic adenovirus cancer gene therapy
  25. PTTG's C-terminal PXXP motifs modulate critical cellular processes in vitro
  26. Epstein–Barr virus: 40 years on
  27. Enhanced efficacy of Escherichia coli nitroreductase/CB1954 prodrug activation gene therapy using an E1B-55K-deleted oncolytic adenovirus vector
  28. An interferon-γ ELISPOT and immunohistochemical investigation of cytotoxic T lymphocyte-mediated tumour immunity in patients with paraneoplastic cerebellar degeneration and anti-Yo antibodies
  29. Expression of the cellular FLICE-inhibitory protein (c-FLIP) protects Hodgkin's lymphoma cells from autonomous Fas-mediated death
  30. Epstein–Barr virus latent membrane protein 1 (LMP1) upregulates Id1 expression in nasopharyngeal epithelial cells
  31. Seasonal differences in the onset of the EBV-positive and -negative forms of paediatric Hodgkin's lymphoma
  32. Mechanism of cell death induced by the novel enzyme-prodrug combination, nitroreductase/CB1954 and identification of synergism with 5-fluorouracil
  33. The effect of Epstein-Barr virus status on outcome in age- and sex-defined subgroups of patients with advanced Hodgkin's disease
  34. Induction of apoptosis by chemotherapeutic drugs: the role of FADD in activation of caspase-8 and synergy with death receptor ligands in ovarian carcinoma cells
  35. LMP1 structure and signal transduction
  36. Frequent expression of the tumor necrosis factor receptor–associated factor 1 in latent membrane protein 1–Positive posttransplant lymphoproliferative disease and HIV-associated lymphomas
  37. South Asian ethnicity and material deprivation increase the risk of Epstein-Barr virus infection in childhood Hodgkin's disease
  38. Gene therapy for hepatocellular carcinoma—teaching old dogs new tricks
  39. Identification of Functional Differences between Prototype Epstein–Barr Virus-Encoded LMP1 and a Nasopharyngeal Carcinoma-Derived LMP1 in Human Epithelial Cells
  40. Epstein-Barr virus: Biology and disease